Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups
暂无分享,去创建一个
Yung-Hyun Choi | S. Moon | W. Kim | S. Yun | H. Kang | Seon-Kyu Kim | Yong-June Kim | Sang-Cheol Lee | Y. Byun | Chuang Zheng | Wun-Jae Kim | X. Piao | S. Moon